slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
7.440 KRW | -2,75% | -.--% | -11,32% |
Vakgebied
Verkoop per activiteit
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Raw Material
64,7
%
| 144 076 | 73,4 % | 139 990 | 64,7 % | -2,84% |
Finished Product
35,3
%
| 52 189 | 26,6 % | 76 368 | 35,3 % | +46,33% |
Verkoop per regio
KRW in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
South Korea
75,4
%
| 132 906 | 67,7 % | 163 116 | 75,4 % | +22,73% |
Asia
22,5
%
| 58 631 | 29,9 % | 48 717 | 22,5 % | -16,91% |
Europe
1,8
%
| 4 409 | 2,2 % | 3 874 | 1,8 % | -12,13% |
Other
0,3
%
| 319 | 0,2 % | 650 | 0,3 % | +103,87% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Tae-Young Kim
CEO | Chief Executive Officer | 65 | - |
Byung-Ok Kim
CTO | Chief Tech/Sci/R&D Officer | 53 | - |
Jae-Taek Hwang
CTO | Chief Tech/Sci/R&D Officer | 60 | - |
Saeng-Gyu Seo
BRD | Director/Board Member | 65 | - |
Kyung-Soo Kim
SAM | Sales & Marketing | 57 | - |
Chun-Bong Lee
SAM | Sales & Marketing | 62 | - |
Do-Kyung Kim
AUD | Comptroller/Controller/Auditor | 56 | - |
Kyu-Jae Lee
SAM | Sales & Marketing | 57 | - |
Jang-Han Lee
PRN | Corporate Officer/Principal | 71 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Tae-Young Kim
CEO | Chief Executive Officer | 65 | - |
Saeng-Gyu Seo
BRD | Director/Board Member | 65 | - |
Jae-Taek Hwang
CTO | Chief Tech/Sci/R&D Officer | 60 | - |
Woo-In Lee
BRD | Director/Board Member | 53 | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 23 906 860 | 9 109 660 ( 38,10 %) | 0 | 38,10 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
MYUNGMOON PHARM CO.,LTD 4.21% | 1 429 642 | 4.21% | 2 161 890 $ |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
-11,32% | 131 mln. | |
+38,20% | 705 mld. | |
+32,82% | 583 mld. | |
-3,77% | 364 mld. | |
+19,90% | 332 mld. | |
+4,94% | 291 mld. | |
+16,64% | 238 mld. | |
-4,13% | 210 mld. | |
+10,63% | 209 mld. | |
+8,73% | 169 mld. |
- Beurs
- Aandelen
- Koers A214390
- Onderneming Kyongbo Pharmaceutical Co., Ltd